Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) will announce its fourth quarter and full year 2020 financial results on March 10, 2021, post market closure. The company will hold a conference call and live webcast at 4:30 p.m. ET to discuss the results and provide a general business update. Interested individuals can access the event through the company's website or by calling the provided numbers. The archived call will be available for at least 30 days following the event. For further details, visit www.fiveprime.com.
- Scheduled release of Q4 and full year 2020 financial results provides transparency.
- Conference call enables direct communication with investors.
- None.
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), will report its fourth quarter and full year 2020 operational and financial results on Wednesday, March 10, 2021 after the U.S. financial markets close. Five Prime will also host a conference call and live audio webcast that same day at 4:30 p.m. (ET) / 1:30 p.m. (PT) to provide a general business update and discuss the company’s financial results.
The live audio webcast may be accessed through the "Events & Presentations" page in the "Investors" section of the company's website at www.fiveprime.com. Alternatively, participants may dial (877) 878-2269 (domestic) or (253) 237-1188 (international) and refer to conference ID: 9872966.
The archived conference call will be available on Five Prime's website beginning approximately two hours after the event and will be archived and available for replay for at least 30 days after the event.
About Five Prime Therapeutics
Five Prime is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com.
Source: Five Prime Therapeutics, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302006083/en/
FAQ
When will Five Prime Therapeutics report its Q4 and full year 2020 results?
What time is the conference call for Five Prime Therapeutics' financial results?
How can I access the Five Prime Therapeutics conference call?
Where can I find more information about Five Prime Therapeutics?
